Sanford Burnham Prebys recruits rising star in cancer research

Brooke Emerling, Ph.D., has joined the Sanford Burnham Prebys Medical Discovery Institute (SBP) as an assistant professor in the Cancer Metabolism and Signaling Networks Program. She has identified a promising new therapeutic target for triple-negative breast cancer and other cancers driven by loss of the tumor suppressor p53--PI5P4Ks, a class of lipid kinases.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews